𝛼SK or SearchIPO Databook: Hangzhou Tangji Medical Technology (HK) - Aug 2026
101 Views30 Aug 2026 10:21
SUMMARY
- Hangzhou Tangji Medical Technology Co., Ltd. is a China-based medical device company established in 2016, providing novel solutions for metabolic diseases. It developed the first medical device approved for digestive.
- The company developed the first medical device approved for digestive endoscopic treatment of obesity in China. The global EBMT market is projected to grow to US$1,248 million by 2030.
- Revenue was RMB23,690 and gross profit was RMB20,110 for the six months ended June 30, 2026. The gross profit margin was 84.9% for the same period.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- IPO Databook: Hangzhou Tangji Medical Technology (HK) - Aug 202630 Aug 2026
x